Mirador Therapeutics

San Diego, United States

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

$250.0M raised

Jan 2026

Series B

Biotechnology Health Care Medical Therapeutics

Top Investors

Blue OwlARCH Venture PartnersSanofiRTW InvestmentsFidelity

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mirador Therapeutics

How much funding has Mirador Therapeutics raised?

Mirador Therapeutics has raised $250.0M in total funding. The most recent round was Series B. The last funding was announced in January 2026.

Who are Mirador Therapeutics's investors?

Mirador Therapeutics's investors include Blue Owl, ARCH Venture Partners, Sanofi, RTW Investments, Fidelity.

Where is Mirador Therapeutics headquartered?

Mirador Therapeutics is headquartered in San Diego, United States.

What does Mirador Therapeutics do?

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

What stage is Mirador Therapeutics at?

Mirador Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 12, 2026.

MLA

"Mirador Therapeutics — Funding & Investors." VCBacked, January 12, 2026, https://www.vcbacked.co/company/mirador-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Mirador Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/mirador-therapeutics

Wikipedia (cite web)

{{cite web |title=Mirador Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mirador-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 12, 2026.